Experimental Alzheimer’s drug slows cognitive decline in trial, firms say
An experimental Alzheimer’s drug slowed cognitive and functional decline by 27 percent in a closely watched clinical trial, the sponsors of the medication said Tuesday, increasing the therapy’s chance for ...